ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4647
0.23%
Brent Oil
82.275
0.37%
Bitcoin
66,075.00
-1.02%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Advanced Accelerator Applications S.A. ADS (delisted) (AAAP)

  7. Advanced Accelerator Applications S.A. ADS (delisted) (AAAP) Noticias

AAAP

ADVANCED ACCELERATOR APPLICATION (AAAP)

Advanced Accelerator Applications S.A. ADS (delisted)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AAAP
FechaHoraFuenteTítuloSímboloCompañía
26/02/201913:06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
03/12/201802:00GlobeNewswire Inc.Advanced Accelerator Applications signs exclusive option and license agreement with FUJIFILM Toyama Chemical to develop and c...NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
12/02/201808:18Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
12/02/201806:00GlobeNewswire Inc.Advanced Accelerator Applications Signs Exclusive License Agreement with Cancer Targeted Technology to Develop CTT1057, an F-...NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
09/02/201812:09Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
01/02/201815:24Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
01/02/201815:24Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
01/02/201815:24Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
01/02/201815:21Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
01/02/201815:05GlobeNewswire Inc.Advanced Accelerator Applications Announces Completion of Subsequent Offering Period for Novartis Tender OfferNASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
01/02/201808:02Edgar (US Regulatory)(25)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
26/01/201811:00GlobeNewswire Inc.Advanced Accelerator Applications Receives US FDA Approval for LUTATHERA® for Treatment of Gastroenteropancreatic Neuroendoc...NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
22/01/201807:00GlobeNewswire Inc.Advanced Accelerator Applications Announces Completion of $3.9 Billion Novartis Tender OfferNASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
07/12/201706:16Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
07/12/201706:00GlobeNewswire Inc.Advanced Accelerator Applications Announces Commencement of Novartis Tender OfferNASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
07/12/201705:05Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
05/12/201715:20Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
05/12/201715:00GlobeNewswire Inc.Advanced Accelerator Applications Board of Directors Recommends $3.9 Billion All Cash Tender Offer by NovartisNASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
24/11/201705:01Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
17/11/201706:39GlobeNewswire Inc.Advanced Accelerator Applications Reports 39% Sales Growth for Third Quarter 2017NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
30/10/201718:46Dow Jones NewsADRs End Mostly Higher; Advanced Accelerator Applications, Braskem Trade ActivelyNASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
30/10/201708:00Dow Jones NewsNovartis to Pay $3.9 Billion for Radio-Pharmaceuticals Firm -- UpdateNASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
30/10/201702:08Dow Jones NewsNovartis to Buy Advanced Accelerator Applications for $3.9 BillionNASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
30/10/201701:00GlobeNewswire Inc.Advanced Accelerator Applications Announces $3.9 Billion All Cash Proposed Tender Offer by NovartisNASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
29/09/201708:16GlobeNewswire Inc.Advanced Accelerator Applications Announces European Approval of Lutetium (177Lu) Oxodotreotide (Lutathera®) for Gastroenter...NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
06/09/201710:03GlobeNewswire Inc.CORRECTING and REPLACING -- Advanced Accelerator Applications S.A.NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
06/09/201706:00GlobeNewswire Inc.Advanced Accelerator Applications and FUJIFILM RI Pharma, Co., LTD Announce First Patient in Bridging Study in Japan for Lute...NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
31/08/201706:00GlobeNewswire Inc.Advanced Accelerator Applications Reports 32% Sales Growth for Second Quarter 2017NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
28/08/201709:08GlobeNewswire Inc.Advanced Accelerator Applications Announces New Prescription Drug User Fee Act (PDUFA) date of January 26, 2018, for Lutetium...NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
27/07/201706:00GlobeNewswire Inc.Advanced Accelerator Applications Completes Resubmission of NDA for Lutetium Lu 177 Dotatate (Lutathera®) to FDANASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
 Showing the most relevant articles for your search:NASDAQ:AAAP

Su Consulta Reciente

CCOM
US500
US 500
USI
USTECH100
US Tech 100
AMEX
XLE
Energy Select Sector SPDR
PM
XAUUSD
Gold vs US Dollar
CCOM
OILBRENT
Brent Oil
CCOM
SILVER
SILVER
NASDAQ
MSFT
Microsoft
AMEX
XLV
Health Care Select Sector
NYSE
DIS
Walt Disney
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
TSLA
Tesla
COIN
ETHUSD
Ethereum
NASDAQ
AAPL
Apple
FX
USDMXN
US Dollar vs MXN
NASDAQ
AMZN
Amazon.com
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados